作者: Bj�rnTore Gjertsen , �ystein Bruserud
DOI: 10.1007/S00262-004-0515-Y
关键词:
摘要: Patients diagnosed with the same malignant disease are often heterogeneous regard to age, complications, cell morphology and tumor histology, stage, prognostic parameters, previous therapy. Many of these factors can affect immunocompetent cells or influence susceptibility immunotherapy. Summaries relevant clinical information should therefore be included in cancer immunology studies increase present as well future scientific impact. Guidelines for selection suggested article.